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Abdominal aortic aneurysm (AAA) is often clinically silent unless
it ruptures, in which case the mortality rate is high [1]. Its prevalence
in Asian populations is 0.14–0.5% [2], while that in Western popula-
tions is 1.0–1.7% [1,3]. We hypothesized that the incidence of AAA in
patients examined during TEE is higher than that in patients exam-
ined using abdominal ultrasonography (AUS). To this end, we pro-
spectively investigated the prevalence and characteristics of AAA
during TTE and AUS.
We included all patients who underwent scheduled TTE from
January 2009 to December 2010 in the outpatient clinic of or while hos-
pitalized at Kitano Hospital (7,765 patients). Exclusion criteria were as
follows: history of AAA (24 patients), clinical symptoms or signs were
thought to be due to AAA for which a TTE was ordered (6 patients),
prior AAA repair (10 patients), and refusal to provide consent (16 pa-
tients). Patients who underwent scheduled AUS in the outpatient clinic
during the same period were analyzed for comparison (15,513 pa-
tients). The exclusion criteria of the AUS analyses were the same as
those of TTE. The exclusion criteria were as follows: history of AAA
(25 patients), clinical symptoms or signs were thought to be due to
AAA for which an AUS was ordered (14 patients), and prior AAA repair
(41 patients). We ultimately analyzed the data of 7,619 patients who
underwent scheduled TTE and compared themwith those of 15,433 pa-
tients who underwent scheduled AUS.
TTE or AUS was ordered by each patient's physician according to
practice guidelines. At the end of the examination, the abdominal
aorta was visualized with the patient in the supine position using the
2D mode with color Doppler. A longitudinal image of the abdominal
aorta was obtained with a sector-type transducer, and then the trans-
ducer was rotated 90° clockwise to scan the central line of the abdomi-
nal aorta, which was traced distally from the subxiphoid window to the
level of the bifurcation of common femoral arteries. AAAwas deﬁned by
an abdominal aorta N 30mm, or a 50% increase in diameter compared to
a normal aorta. Clinical data and comorbidities were collected from an
electronic medical records database. Comorbidities were regarded as
present when these diagnoses were recorded in the hospital charts.
The research protocol was approved by the Institutional Review Board
of Kitano Hospital according to the ethical guidelines of the 1975
Declaration of Helsinki.
On statistical analyses, differences in continuous variables between
the TTE and AUS groupswere analyzed using two-way factorial analysis
followed by post-hoc comparisons with the Bonferroni test, whilehttp://dx.doi.org/10.1016/j.ijchv.2014.06.003
2214-7632/© 2014 Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-NDdifferences in categorical variables were analyzed using the chi square
test and the Cochran–Mantel–Haenszel test between two groups
and among three or more groups, respectively. In all tests, values of
p b 0.05 were considered signiﬁcant.
Males comprised 52.3% of the TTE group and 41.0% of the AUS group
(Table 1); themean ages were 66.1 (SD, 15.1) and 52.9 (SD, 17.5) years,
respectively, while the mean number of comorbidities was 1.76
and 0.09, respectively. These data indicated that the patients who
underwent a scheduled TTE while hospitalized had more risk
factors of atherosclerotic diseases than patients who underwent
AUS.
AAA was identiﬁed in 136 patients during TTE (1.8%) and in 95 pa-
tients during AUS (0.6%) (Table 1). The prevalence of AAA was higher
in the TTE group (odds ratio, 2.93; 95% conﬁdence interval [95% CI],
2.25–3.81) than in AUS group. The percentage of patients in the TTE
group whose AAA was N50 mm in diameter was 25.7%, which was sig-
niﬁcantly higher than that of patients in the AUS group (3.1% and sup-
plementary table). Of note, the patients with AAA in both groups had
a larger mean number of comorbidities and were older (Table 1). In
patients who underwent TTE, ischemic heart disease, cerebrovascu-
lar disease, and hypertension are signiﬁcant risks of having AAA
(Supplemental Fig. 1).
Subgroup analyses of patients N 65 years of age showed an AAA
prevalence of 2.55%, higher than that of patients N 65 years in the AUS
group (Fig. 1).
According to published guidelines and meta-analyses [1,4],
men ≥ 60 years of age with a family history of AAA or men 65–75
years of age with a history of smoking are encouraged to undergo
AAA screening. This indicates the necessity of targeting high-risk pa-
tients. Although the routine detection of AAA during TEE has been re-
ported to be useful by several studies [5,6], the proﬁles of patients
with AAA during TEE were not previously well documented. Our data
showed the importance of an additional examination for AAA during
scheduled TTE in patients N65 years of agewith atherosclerotic diseases
or multiple risk factors [7,8].
TTE can be used to quickly and easily examine AAA and adds only
2–5 min [5] since the same probe was used with the patients in the su-
pine position. Although we did not perform cost–beneﬁt analyses, AUS
costs an additional $70–100 dollars per examination in Japan.
Clinical perspectives included: 1) development of an efﬁcient AAA
screening using TTE; and 2) assessment of its prognostic value and
cost-effectiveness. Follow-up studies and simultaneous assessment
using TTE and other imagingmodalities in the same patients are needed
to achieve these perspectives in multicenter studies.
There are several limitations to the present study. First, we com-
pared only selected patients who underwent TTE with those who
underwent AUS, instead of individuals in the general population.
Second, the prevalence of AAA during TTE was low. However, com-
pared with the prevalence of 0.14–0.5% in Asian populations [2],
the prevalence of 1.8% overall and 2.55% in patients N65 years of
age makes the routine examination during TTE worthwhile in dailylicense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Characteristics of study population and AAA.
TTE AUS p value
Total number 7619 15,433
Age (mean, SD) 66.1 (15.1) 52.9 (17.5) p b 0.001
Male (%) 3985 (52.3) 6338 (41.1) p b 0.001
Number of comorbidities (%)
5 1926 (25.2) 859 (5.5)
4 199 (2.6) 315 (2.0)
3 232 (3.0) 625 (4.0)
2 317 (4.1) 784 (4.8)
1 1484 (19.4) 219 (1.4)
0 3461 (45.4) 12,667 (82.1)
Mean no. of comorbidities 1.74 0.09 p b 0.001
Comorbidities (%)
Ischemic heart diseases 2358 (30.9) 3253 (10.5)
Cerebrovascular diseases 1928 (25.3) 2945 (9.1)
Hypertension 4160 (54.6) 2072 (21.0)
Diabetes mellitus 2175 (28.5) 1409 (19.0)
Hyperlipidemia 2125 (27.8) 1629 (13.4)
Total number, prevalence of AAA 136 (1.73%) 95 (0.61%) p b 0.001
Age of those with AAA (mean, SD) 72.4 (9.1) 73.7 (5.8) p = 0.34
Male (%) of those with AAA 100 (73.5) 69 (72.6)
No. of comorbidities (%) of those with AAA
5 46 (33.8) 12 (12.6)
4 5 (3.6) 2 (2.1)
3 8 (5.8) 17 (17.9)
2 16 (11.7) 10 (10.5)
1 23 (16.9) 12 (12.6)
0 36 (27.4) 42 (44.2)
Mean no. of comorbidities 2.41 1.58 p = 0.002
Comorbidities (%) of those with AAA
Ischemic heart diseases 75 (55.1) 24 (25.2) p b 0.0001
Cerebrovascular diseases 54 (39.7) 19 (20.0) p = 0.07
Hypertension 99 (72.9) 53 (55.7) p = 0.01.
Diabetes mellitus 56 (41.1) 33 (34.7) P = 0.48
Hyperlipidemia 47 (34.5) 36 (37.8) p = 0.54
No. of AAA N50 mm 16 1
Prevalence of N50 mm of those with AAA 11.7% 1.1% p b 0.001
TTE; transthoracic echocardiography. AUS; abdominal ultrasonography. AAA; abdominal aortic aneurysm.
224 Letter to the Editorpractice [8]. Third, smoking data [9] were not included in our
database.
In conclusion, the prevalence of AAA detected on TTE was higher
(1.8% of all patients and 2.55% of patients N65 years of age) than thatFig. 1. Age distribution of AAA detected and subgroup analyses.detected on AUS (0.6%) in the hospital, which is comparable to that of
the general population (0.14–0.5%).
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